Vega Therapeutics, Inc., a clinical stage biotechnology company developing novel therapies for rare blood disorders, announced that the U.S. Food and Drug Administration (FDA)...
Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery and development, announced...
Rocket Pharmaceuticals, Inc, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need,...
Axcelis Technologies, Inc, a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced shipment of multiple Purion H200 SiC Power Series™...
EnCompass Technologies, Inc., a privately held medical device company focused on protecting patients from brain injury during cardiovascular procedures, announced its novel F2 cerebral embolic...
